Home › Grants › United States › Cell and Gene Therapy (CGT) Access Model (Assistance Listing 93.885)

Cell and Gene Therapy (CGT) Access Model (Assistance Listing 93.885)

The Cell and Gene Therapy (CGT) Access Model aims to improve the lives of people with Medicaid living with rare and severe diseases by increasing access to potentially transformative treatments.

Grant (non-repayable) Check the official page for current intake dates

Funder

Centers for Medicare and Medicaid Services (listed as Health And Human Services, Department Of / Centers For Medicare And Medicaid Services)
Funder profile and all of its programs

Amount

CMS may award a maximum of $9.55 million in Cooperative Agreement award funding to each selected recipient over the course of up to 10.5 years.

Where

United States (federal)

Eligibility

Open to state, provincial, local or tribal governments. Federal assistance program (Cooperative Agreement); individual funding notices set the dates.

Sectors

Health and life sciences, Manufacturing, Municipal, state and local government

Deadline

Varies: check the official page for current dates

Source

SAM.gov Assistance Listings (93.885)

Last checked

2 November 2026

Funder contacts

Public organizational contacts on file Unlock full profile / Sign up

Official page ↗

From official open data: listed in the official SAM.gov Assistance Listings on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.

Related grant lists

Health and life sciences Manufacturing Municipal, state and local government Governments and public bodies United States United States (national) Federal agency

Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.